You just read:

Ipsen Biopharmaceuticals, Inc. Announces Eight Presentations for Dysport® (abobotulinumtoxinA) at the Annual Meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine

News provided by

Ipsen Biopharmaceuticals, Inc.

Sep 15, 2016, 16:03 ET